Repligen Corporation
165.05USD
-3.4800 (-2.06%)
Computing valuation metrics…
Valuation
P/E (TTM)
228.97x
P/E (Forward)
63.90x
EV/EBITDA
65.50x
EV/Revenue
11.96x
P/S (TTM)
12.11x
P/B
4.50x
FCF Yield
1.18%
Dividend Yield
0.00%
Gross Margin
53.84%
Operating Margin
8.23%
Net Margin
5.29%
Peer Comparison — Medical Instruments & Supplies
| Company | Mkt Cap | P/E | EV/EBITDA | FCF Yield | Rev Growth | Div Yield |
|---|---|---|---|---|---|---|
| RGENRepligen Corporation | $9.51B | 228.97x | 65.50x | 1.18% | 11.93% | 0.00% |
| ISRGIntuitive Surgical, Inc. | $126.56B | 40.51x | 28.63x | 2.07% | 18.50% | — |
Subject metrics from SEC filings where available; peer metrics from cached market data.
| $48.98B |
| 31.11x |
| 10.63x |
| 9.14% |
| 5.40% |
| 2.35% |
| MDLNMedline Inc. | $45.81B | 42.56x | 18.79x | 1.86% | 11.60% | — |
| RMDResMed Inc. | $31.89B | 21.17x | 14.91x | 2.95% | 8.60% | 1.16% |
| WSTWest Pharmaceutical Services, Inc. | $23.71B | 43.20x | 25.93x | 1.17% | 13.80% | 0.26% |
| SOLVSolventum Corporation | $15.34B | 11.02x | 17.76x | 3.19% | 2.20% | — |
| BAXBaxter International Inc. | $12.61B | — | 10.67x | 7.93% | 5.30% | 0.16% |
| COOThe Cooper Companies, Inc. | $12.38B | 53.80x | 16.89x | 3.43% | 7.90% | — |